Clinical Chemistry Analyzers Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Clinical Chemistry Analyzers Market Outlook
Clinical Chemistry Analyzer Market size is expected to attain US$ 19.02 Billion by 2030, according to Renub Research. Clinical chemistry refers to the biochemical analysis of the frame fluids, in which extraordinary chemical reactions are observed to determine the volume of diverse chemicals. Clinical chemistry, a clinical pathology department, assesses frame fluids for disease prognosis and treatment. It's used in metabolic feature tests, like diabetes and drug-of-abuse screening. Clinical analyzer's automated devices employ ion-selective potentiometry, latex agglutination, and photometric/colorimetric testing to examine blood serum, plasma, and urine.
Worldwide available analyzers include:
- Benchtop fashions
- Compact bedside devices (with fewer tests)
- High-throughput floor-primarily based machines
The worldwide clinical chemistry analyzer market flourishes due to technological advancements, accelerated health awareness, and efforts by healthcare industries to improve facts and reliability. Yet, demanding situations include high costs, a scarcity of educated professionals, and uncertainty risks.
An extensive driving force in the market is the rising incidence of chronic diseases like diabetes. The ongoing surge in disease occurrence has compelled companies to mass-produce advanced analyzers for progressive diagnostic capabilities. Consequently, intense competition has emerged because of the demand for chemical analyzers and the substantial inflow of the latest market providers. Technological improvements in clinical chemistry analyzers have enabled broader testing skills and early sickness detection, particularly in specialized sectors like cancer, gynecology, and endocrinology. Notable improvements consist of enhanced resolution, refined pattern reputation, computer-assisted interpretation, advanced modeling, parameter estimation, and the integration of artificial intelligence.
According to the WHO, through 2030, about 1 in 6 human beings may be elderly (60 or older), with the worldwide elderly population expected to reach 1.4 billion in 2030 (up from 1 billion in 2020) and expected to achieve 2.1 billion with the aid of 2050. The GLOBOCAN 2020 record states that the global cancer instances in 2020 were about 19.3 million, projected to grow to 28.9 million with the assistance of 2040. The IDF Diabetes Atlas, Tenth Edition 2021, reports 537 million adults with diabetes in 2021, expected to attain 643 million by 2030 and 783 million by 2045 globally.
Clinical chemistry analyzer market is anticipated to develop at a CAGR of 4.35% during the forecast duration (2023–2030)
The clinical chemistry and immunochemistry analyzers allow immunoassay-primarily-based testing, which greatly increases the spectrum of assessments that can be performed on a single device and reduces the time required for high-quality checks and protection of those analyzers. The automatic and integrated analyzers come in one-of-a-kind sample workloads and volumes (low, medium, and excessive) to shape the necessities of the health facility and reference labs, similarly contributing to growing demand and market increase. Thus, the increasingly aged populace is vulnerable to numerous persistent illnesses, resulting in an excessive need for medical tests. The clinical chemistry analyzer industry is expected to grow over the forecast period. The clinical chemistry analyzer market is worth US$ 14.12 Billion in 2023.
Reagents market is about to preserve its growth, which is crucial for advancing clinical diagnostics
By Product Type, The global clinical chemistry analyzer market is segmented into analyzers, reagents, and others. The global clinical chemistry analyzer market witnesses the reagents market reigning supreme as it claims the top position. This dominance is driven by reagents' pivotal role in facilitating accurate diagnostic tests and clinical research. These essential chemical substances enable clinical chemistry analyzers to detect and measure various biomarkers, making them indispensable in the healthcare industry. As the demand for advanced medical diagnostics continues to surge worldwide, the reagents market remains at the forefront, ensuring the reliable functioning of clinical chemistry analyzers and contributing significantly to advancements in medical science and patient care.
Basic Metabolic Panel (BMP) holds the biggest market within the clinical chemistry analyzer industry
By Test Type, the global clinical chemistry analyzer market is divided into Basic Metabolic Panels, Liver Panels, Renal Profiles, Lipid Profiles, Thyroid Function Panels, Electrolyte Panels, and Specialty Chemical Assessments. The Basic Metabolic Panel (BMP) commands the largest market share in the clinical chemistry analyzer industry. This comprehensive diagnostic tool is crucial in assessing a patient's health by measuring key metabolic markers such as glucose, calcium, and electrolytes. Its widespread adoption stems from its ability to provide essential insights into various physiological functions, aiding in the early detection and management of metabolic disorders and chronic conditions. As healthcare systems worldwide prioritize preventive care and early intervention, the BMP's prominence is set to continue, making it a cornerstone in the medical chemistry analyzer landscape and improving patient outcomes.
Hospitals have emerged as the dominant clinical chemistry analysis industry players, securing the best market share
By End User, the global clinical chemistry analyzer market is segmented into Hospitals, Research Laboratories & Institutes, Diagnostic Laboratories, and Others. Hospitals have become prominent in the clinical chemistry analyzers industry, securing most market revenues. This shift underscores the pivotal role that healthcare institutions play in patient diagnosis, treatment, and monitoring. Clinical chemistry analyzers, renowned for their capability to deliver precise measurements of diverse biomarkers, have become essential instruments in hospital laboratories. They empower healthcare providers to make informed decisions regarding patient care, enhancing the accuracy of diagnoses and treatment strategies. As the demand for advanced medical diagnostics and comprehensive patient care continues to expand, hospitals continue to lead in innovation and maintain their position as top market performers in this crucial sector.
United States boasts a thriving clinical chemistry analyzer industry characterized by innovation, advanced generation, and great market presence
By country, the Global Clinical Chemistry Analyzers Market is segmented into the United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia, UAE, and Rest of World. The United States is home to a vibrant clinical chemistry analyzer industry, characterized by its proud tradition of cutting-edge innovation and a robust research and development framework. This nation takes the lead in the global market for manufacturing advanced diagnostic equipment, enjoying a reputation for excellence in healthcare. The industry's success is underpinned by a strong dedication to delivering superior healthcare solutions and responding to the growing demand for precise diagnostics. U.S.-based manufacturers continually introduce state-of-the-art clinical chemistry analyzers that cater to the evolving requirements of healthcare providers. This thriving sector significantly benefits domestic healthcare and extends its global influence by exporting products, establishing the United States as a dominant force in advancing healthcare worldwide through clinical chemistry analyzers.
Key Player
Some clinical chemistry analyzer market players are Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA Ltd., and Hitachi.
Renub Research latest report “Clinical Chemistry Analyzer Market Global Forecast by Product Type (Analyzers, Reagents and Others), By Test Type (Basic Metabolic Panel, Electrolyte Panel, Liver Panel, Liver Profile, Renal Profile, Thyroid Functional Panel and Specialty Chemical Tests), By End Users (Hospitals, Academic Research Centers, Diagnostic Laboratories and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Key Players Analysis (Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA, Ltd and Hitachi)" provides a detailed analysis of Global Clinical Chemistry Industry.
Product Type
1. Analyzers
2. Reagents
3. Others
Test Type
1. Basic Metabolic Panel
2. Liver Panel
3. Renal Profile
4. Lipid Profile
5. Thyroid Function Panel
6. Electrolyte Panel
7. Specialty Chemical tests
End User
1. Hospitals
2. Diagnostic Laboratories
3. Research Laboratories & Institutes
4. Others
Region
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Netherlands
2.6 Spain
3. Asia Pacific
3.1 China
3.2 South Korea
3.3 Japan
3.4 India
3.5 Indonesia
3.6 Malaysia
3.7 Australia
4. Latin America
4.1 Argentina
4.2 Brazil
4.3 Mexico
4.4 Colombia
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 Israel
5.4 South Africa
6. Rest of World
Key Players
1. Thermo Fisher Scientific
2. Abbott Laboratories
3. Siemens Healthineers
4. Danaher Corporation
5. Johnson & Johnson
6. Sysmex ADR
7. HORIBA Ltd
8. Hitachi
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2018 - 2023 |
| Forecast Period | 2024 - 2030 |
| Market | US$ Billion |
| Segment Covered | Product Type, Test Type, End User, and Country |
| Region Covered | United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Australia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, UAE, Israel, South Africa and Rest of World |
| Companies Covered | Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Johnson & Johnson, Sysmex ADR, HORIBA, Ltd and Hitachi |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Clinical Chemistry Analyzers Market
6. Market Share – Global Clinical Chemistry Analyzers Market
6.1 By Product Type
6.2 By Test Type
6.3 By End User
6.4 By Country
7. Product Type – Global Clinical Chemistry Analyzers Market
7.1 Analyzers
7.2 Reagents
7.3 Others
8. Test Type – Global Clinical Chemistry Analyzers Market
8.1 Basic Metabolic Panel
8.2 Liver Panel
8.3 Renal Profile
8.4 Lipid Profile
8.5 Thyroid Function Panel
8.6 Electrolyte Panel
8.7 Specialty Chemical tests
9. End User – Global Clinical Chemistry Analyzers Market
9.1 Hospitals
9.2 Diagnostics Laboratory
9.3 Research Laboratories & Institutes
9.4 Others
10. Countries – Global Clinical Chemistry Analyzers Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Netherlands
10.2.6 Spain
10.3 Asia Pacific
10.3.1 China
10.3.2 South Korea
10.3.3 Japan
10.3.4 India
10.3.5 Indonesia
10.3.6 Malaysia
10.3.7 Australia
10.4 Latin America
10.4.1 Argentina
10.4.2 Brazil
10.4.3 Mexico
10.4.4 Colombia
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 Israel
10.5.4 South Africa
10.6 Rest of World
11. Porter’s Five Forces Analysis – Global Clinical Chemistry Analyzers Market
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis – Global Clinical Chemistry Analyzers Market
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players
13.1 Thermo Fisher Scientific
13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue
13.2 Abbott Laboratories
13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue
13.3 Siemens Healthineers
13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue
13.4 Danaher Corporation
13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue
13.5 Johnson & Johnson
13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue
13.6 Sysmex ADR
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue
13.7 HORIBA, Ltd.
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue
13.8 Hitachi
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue
List of Figures:
Figure-01: Global – Clinical Chemistry Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Clinical Chemistry Market (Billion US$), 2024 – 2030
Figure-03: Product Type – Analyzers Market (Million US$), 2018 – 2023
Figure-04: Product Type – Forecast for Analyzers Market (Million US$), 2024 – 2030
Figure-05: Product Type – Reagents Market (Billion US$), 2018 – 2023
Figure-06: Product Type – Forecast for Reagents Market (Billion US$), 2024 – 2030
Figure-07: Product Type – Others Market (Billion US$), 2018 – 2023
Figure-08: Product Type – Forecast for Others Market (Billion US$), 2024 – 2030
Figure-09: Test Type – Basic Metabolic Panel Market (Million US$), 2018 – 2023
Figure-10: Test Type – Forecast for Basic Metabolic Panel Market (Million US$), 2024 – 2030
Figure-11: Test Type – Liver Panel Market (Million US$), 2018 – 2023
Figure-12: Test Type – Forecast for Liver Panel Market (Million US$), 2024 – 2030
Figure-13: Test Type – Renal Profile Market (Million US$), 2018 – 2023
Figure-14: Test Type – Forecast for Renal Profile Market (Million US$), 2024 – 2030
Figure-15: Test Type – Lipid Profile Market (Million US$), 2018 – 2023
Figure-16: Test Type – Forecast for Lipid Profile Market (Million US$), 2024 – 2030
Figure-17: Test Type – Thyroid Function Panel Market (Million US$), 2018 – 2023
Figure-18: Test Type – Forecast for Thyroid Function Panel Market (Million US$), 2024 – 2030
Figure-19: Test Type – Electrolyte Panel Market (Million US$), 2018 – 2023
Figure-20: Test Type – Forecast for Electrolyte Panel Market (Million US$), 2024 – 2030
Figure-21: Test Type – Specialty Chemical tests Market (Million US$), 2018 – 2023
Figure-22: Test Type – Forecast for Specialty Chemical tests Market (Million US$), 2024 – 2030
Figure-23: End User – Hospital Market (Million US$), 2018 – 2023
Figure-24: End User – Forecast for Hospital Market (Million US$), 2024 – 2030
Figure-25: End User – Diagnostics Laboratories Market (Million US$), 2018 – 2023
Figure-26: End User – Forecast for Diagnostics Laboratories Market (Million US$), 2024 – 2030
Figure-27: End User – Research Laboratories & Institutes Market (Million US$), 2018 – 2023
Figure-28: End User – Forecast for Research Laboratories & Institutes Market (Million US$), 2024 – 2030
Figure-29: End User – Others Market (Million US$), 2018 – 2023
Figure-30: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-31: United States – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-32: United States – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-33: Canada – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-34: Canada – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-35: Germany – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-36: Germany – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-37: United Kingdom – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-38: United Kingdom – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-39: France – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-40: France – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-41: Italy – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-42: Italy – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-43: Netherlands – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-44: Netherlands – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-45: Spain – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-46: Spain – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-47: China – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-48: China – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-49: South Korea – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-50: South Korea – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-51: Japan – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-52: Japan – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-53: India – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-54: India – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-55: Indonesia – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-56: Indonesia – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-57: Malaysia – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-58: Malaysia – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-59: Australia – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-60: Australia – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-61: Argentina – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-62: Argentina – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-63: Brazil – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-64: Brazil – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-65: Mexico – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-66: Mexico – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-67: Colombia – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-68: Colombia – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-69: Saudi Arabia – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-70: Saudi Arabia – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-71: UAE – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-72: UAE – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-73: Israel – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-74: Israel – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-75: South Africa – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-76: South Africa – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-77: Rest of World – Clinical Chemistry Analyzers Market (Million US$), 2018 – 2023
Figure-78: Rest of World – Forecast for Clinical Chemistry Analyzers Market (Million US$), 2024 – 2030
Figure-79: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2023
Figure-80: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-81: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2023
Figure-82: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-83: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2023
Figure-84: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-85: Danaher Corporation – Global Revenue (Billion US$), 2018 – 2023
Figure-86: Danaher Corporation – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-87: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2023
Figure-88: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-89: Sysmex ADR – Global Revenue (Million US$), 2018 – 2023
Figure-90: Sysmex ADR – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-91: HORIBA, Ltd. – Global Revenue (Million US$), 2018 – 2023
Figure-92: HORIBA, Ltd. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-93: Hitachi – Global Revenue (Billion US$), 2018 – 2023
Figure-94: Hitachi – Forecast for Global Revenue (Billion US$), 2024 – 2030
List of Tables:
Table-01: Global – Clinical Chemistry Market Share by Product Type (Percent), 2018 – 2023
Table-02: Global – Forecast for Clinical Chemistry Market Share by Product Type (Percent), 2024 – 2030
Table-03: Global – Clinical Chemistry Market Share by Test Type (Percent), 2018 – 2023
Table-04: Global – Forecast for Clinical Chemistry Market Share by Test Type (Percent), 2024 – 2030
Table-05: Global – Clinical Chemistry Market Share by End Users (Percent), 2018 – 2023
Table-06: Global – Forecast for Clinical Chemistry Market Share by End Users (Percent), 2024 – 2030
Table-07: Global – Clinical Chemistry Market Share by Regions (Percent), 2018 – 2023
Table-08: Global – Forecast for Clinical Chemistry Market Share by Regions (Percent), 2024 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com